Jump to

SAFE Conversion in a Turkish Joint-Stock Company: Capital Increase, Pre-emption and Share Premium (TCC Arts. 461, 519)

SAFE Conversion in a Turkish Joint-Stock Company: Capital Increase, Pre-emption and Share Premium (TCC Arts. 461, 519)

A SAFE is signed in an afternoon. When the priced round arrives and the lead investor’s counsel asks for the “conversion mechanics”, the founders discover that nothing in the Turkish Commercial Code No. 6102 (TCC) mentions a SAFE. The instrument gives the investor a contractual right to shares at a future price; Turkish company law hands out shares only through a formally resolved and registered capital increase (sermaye artırımı). This article walks through that bridge for a joint-stock company (anonim şirket, A.Ş.), from the resolution and the Article 461 pre-emption restriction to premium, set-off, registration and the conditional capital alternative of Articles 463 to 472. The worked example uses the figures of the SAFE dilution calculator; the choice of instrument is covered in the SAFE or convertible note framework.

Step one: the capital increase resolution and its quorum

In the basic capital system (esas sermaye sistemi), the usual case for a startup, Article 456(2) gives the decision to the general assembly acting under Article 459; the capital clause of the articles of association (esas sözleşme) is amended, a non-delegable power under Article 408(2)(a). Under Article 456(1) capital cannot be increased, except from internal sources, while cash contributions on existing shares remain unpaid (immaterial amounts aside), so founders settle any outstanding initial subscriptions first. The resolution follows Article 421(1): at least half of the share capital represented and a majority of the votes present; a second meeting within one month needs one third, and articles provisions lowering these quorums are invalid. If the round creates preferred shares, Article 421(3)(b) requires the affirmative votes of at least seventy-five per cent of the capital for the creation of privileged shares (imtiyazlı pay), a quorum that under Article 421(4) does not fall at a second meeting. In the registered capital system (kayıtlı sermaye sistemi) the board decides under Article 460(1), but under Article 460(4) it may issue premium shares and restrict pre-emption rights only if the articles expressly authorise it.

Step two: restricting the pre-emption right (Article 461)

Under Article 461(1) every shareholder may take the new shares in proportion to its existing holding, so a conversion works only if the founders stand aside. Article 461(2) permits this on conditions: “Genel kurulun, sermayenin artırımına ilişkin kararı ile pay sahibinin rüçhan hakkı, ancak haklı sebepler bulunduğu takdirde ve en az esas sermayenin yüzde altmışının olumlu oyu ile sınırlandırılabilir veya kaldırılabilir. Özellikle, halka arz, işletmelerin, işletme kısımlarının, iştiraklerin devralınması ve işçilerin şirkete katılmaları haklı sebep kabul olunur. Rüçhan hakkının sınırlandırılması ve kaldırılmasıyla, hiç kimse haklı görülmeyecek şekilde, yararlandırılamaz veya kayba uğratılamaz.” In plain terms: the pre-emption right (rüçhan hakkı) may be restricted or removed only for justified reasons and with the affirmative votes of at least sixty per cent of the share capital; a public offering, the acquisition of undertakings, parts of undertakings or participations, and employee participation are expressly accepted as justified reasons; and no one may be unjustifiably advantaged or harmed.

The sixty per cent is of the entire capital, not of the votes present, so founders holding fifty-five per cent cannot carry it against an absent co-founder. Investor entry is not among the listed examples, which are introduced by “özellikle” and are not exhaustive, so the reasoning goes into the board report the same paragraph requires (reasons for the restriction, why the shares carry a premium, how it was calculated), which is registered and announced; under Article 457(2)(a) the board’s declaration must also document the amount and ratio of the restriction and to whom, why and at what price the unused rights were allocated.

If you would like to discuss how this applies to your company, you can book a call.

Step three: price, nominal value and share premium

A SAFE converts at a price far above the nominal value (itibarî değer) of the shares, which under Article 476(1) is at least one kuruş and in practice often one lira. Article 347(1) states both rules: shares may not be issued below nominal value, and may be issued above it only if the articles so provide or the general assembly so resolves. The excess is the share premium (çıkarma primi). Article 344(1), applied to increases by Article 459(3), requires at least twenty-five per cent of the nominal value before registration and the rest within twenty-four months, but “payların çıkarma primlerinin tamamı tescilden önce ödenir”: the whole premium is paid before registration, into the bank account of Article 345(1).

The premium then stops being free money. Under Article 519(2)(a) the premium on new shares, net of issue costs, redemption provisions and charitable payments, is added to the general legal reserve (genel kanuni yedek akçe), even after the reserve has reached the twenty per cent of paid-in capital ceiling of Article 519(1). Under Article 519(3), as long as the reserve does not exceed half of the capital, it may be used only to cover losses, to keep the business going in bad times or to prevent or mitigate unemployment; the part above that level is not so restricted. A round priced at fifty lira per one-lira share therefore puts forty-nine fiftieths of the money into a reserve, not a dividend pool.

Step four: paying by set-off of the investor’s claim

The new investors pay cash; the SAFE holder paid long ago and holds a claim against the company. The Code has no provision on converting a SAFE, so the step rests on general rules. Article 342(1), applied by Article 459(3), excludes claims not yet due (vadesi gelmemiş alacaklar), so the SAFE must make the claim due on the closing of the priced round; a claim contributed as in-kind capital would need valuation by court-appointed experts under Article 343(1). Practice takes a different route, which the Code acknowledges: the SAFE holder subscribes for cash and sets off its claim against the subscription price. Under Article 139(1) of the Turkish Code of Obligations No. 6098 (TBK) two persons owing each other sums of money may set off if both debts are due, and under Article 143(1) the set-off takes effect on declaration. The TCC contemplates this in the board’s declaration: Article 457(2)(a) requires, “bir borcun takası söz konusu ise, bu borcun varlığı, geçerliliği ve takas edilebilirliği”, documented explanations of the existence, validity and set-off eligibility of the debt. The Code goes no further; the documents the trade registry expects are a matter of practice to be checked before the meeting date is fixed. Some parties sidestep the question by having the SAFE holder pay cash and the company repay the advance after registration; that is a liquidity choice, not a legal requirement.

Worked example: from percentages to nominal value and premium

An investor puts 1,000,000 into a post-money SAFE with an 8,000,000 cap. The holder’s stake immediately before the priced round is investment divided by cap: 1,000,000 / 8,000,000 = 12.5 per cent, after conversion but before new money. The round is agreed at 40,000,000 pre-money with 10,000,000 of new money, so 50,000,000 post-money. The new investors take 20 per cent and everyone already there is diluted by that 20 per cent: the SAFE holder ends with 12.5 x 0.8 = 10 per cent, the founders with 87.5 x 0.8 = 70 per cent; the post-money SAFE entry has the detail.

Now the company law layer. Assume the founders hold 700,000 shares of one lira. For them to end at 70 per cent the total must be 1,000,000 shares: 100,000 for the SAFE holder and 200,000 for the new investors, so the capital rises from 700,000 to 1,000,000 lira. The SAFE conversion price is the cap divided by the capitalisation including the SAFE shares: 8,000,000 / 800,000 = 10 lira per share, so each SAFE share is issued at 1 lira nominal plus 9 lira premium, and 100,000 x 10 = 1,000,000 lira is exactly the amount set off. The round price is 40,000,000 / 800,000 = 50 lira per share: 1 lira nominal plus 49 lira premium, and 200,000 x 50 = 10,000,000 lira of new money.

Holder Shares (1 lira nominal) Price per share Nominal Premium (Art. 519(2)(a)) Total Stake after round
Founders (existing) 700,000 n/a 700,000 0 n/a 70%
SAFE holder (set-off) 100,000 10 100,000 900,000 1,000,000 10%
New investors (cash) 200,000 50 200,000 9,800,000 10,000,000 20%
Total after round 1,000,000 1,000,000 10,700,000 100%

The SAFE holder and the new investors pay different prices for the same class of share in one resolution, which Article 347(1) allows but the Article 461(2) report must explain: the lower price rewards money advanced earlier at higher risk. The whole 10,700,000 lira premium lands in the legal reserve.

Step five: registration, the share ledger and the three-month limit

Under Article 455(1), applied to increases by Article 456(5), the board registers the amending resolution with the trade registry of the company’s seat and branches, has it announced and places it on the company’s website; the amendment has no effect against third parties before registration. Article 456(3) adds a deadline: an increase not registered within three months of the resolution lapses and payments are returned under Article 345(2). The new shareholders are then entered in the share ledger (pay defteri) under Article 499(1); under Article 499(4) only the person recorded there is a shareholder towards the company, so an investor missing from the ledger cannot vote at the first general assembly after the round.

The shareholders’ agreement and the conditional capital alternative

None of this happens by itself. The shareholders’ agreement (pay sahipleri sözleşmesi) and the round documents turn the SAFE holder’s claim into obligations: founders undertake to vote for the increase and the pre-emption restriction, accept the set-off and register in time; the SAFE holder undertakes to sign the subscription undertaking and accede to the agreement. Because Article 461(2) counts sixty per cent of the capital, it should bind every minority founder or angel needed to reach it. The anatomy of a shareholders’ agreement lists the clauses; the dilution mathematics entry covers the arithmetic.

Could the conditional capital increase (şarta bağlı sermaye artırımı) of Articles 463 to 472 make conversion self-executing? Under Article 463(2) the capital increases automatically when the conversion or subscription right is exercised and the contribution is satisfied by set-off or payment. But Article 463(1) fixes the beneficiaries: rights may be granted in the articles to “yeni çıkarılan tahviller veya benzeri borçlanma araçları nedeniyle, şirketten veya topluluk şirketlerinden alacaklı olanlara veya çalışanlara”, that is, to creditors of the company or of group companies by reason of newly issued bonds or similar debt instruments, and to employees. A convertible note issued as a debt instrument fits that wording; a SAFE, which is not a loan and is usually not structured as a debt instrument, fits it awkwardly, and the Code does not say whether it qualifies. The mechanism also carries a cap of half the share capital (Article 464(1)), nullity of rights granted before the articles provision is registered (Article 465(3)) and the existing shareholders’ right to be offered the instruments first (Article 466(1)). For employee options this is the right tool, as the article on the conditional capital increase and ESOPs explains; for a SAFE signed before any articles provision exists, the ordinary increase with a pre-emption restriction remains the standard route.

Can the money the SAFE investor paid a year ago simply count as paid-in capital now?

Not by itself. The payment created a claim, not shares. At conversion the investor signs a subscription undertaking under Article 459(2) and the claim is set off against the price; the board’s declaration under Article 457(2)(a) documents the debt, and the claim must be due under Article 342(1).

The founders hold exactly sixty per cent and one co-founder is unhappy. Can the conversion still pass?

Only if the whole sixty per cent votes in favour. Article 461(2) counts the affirmative votes on the entire share capital, so a dissenting co-founder with even one per cent breaks the threshold; hence the voting undertakings in shareholders’ agreements.

The priced round is delayed. Can the capital increase resolution wait on the shelf?

For three months at most: under Article 456(3) an increase not registered within three months of the resolution lapses. The safer sequence is to sign the round documents with conditions precedent, hold the general assembly when the money is ready, and register immediately.

Related: SAFE dilution calculator · SAFE or convertible note · post-money SAFE · SAFE.

Sources. Turkish Commercial Code No. 6102 (Articles 342-345, 347, 408, 421, 455-457, 459-461, 463-466, 476, 499, 519); Turkish Code of Obligations No. 6098 (Articles 139, 143). Statute links open the official Turkish texts on mevzuat.gov.tr.

This article is provided for general information only and does not constitute legal advice. Please seek legal support for an assessment of any specific matter.

Author

  • Erdem Mümtaz Hacıpaşaoğlu

    Mümtaz is the Managing Partner of Vircon Legal, which he founded in 2016. He advises founders, investors and operators on financing rounds, M&A, cross-border incorporations and regulated verticals such as crypto-asset infrastructure, fintech and games, bringing a former startup founder's perspective to every engagement. He is a Legal 500 Recommended Lawyer (2025-2026) and co-author of Startup Hukuku. Personal site · Open-access legal guides

    View all posts
Considering a similar matter?See how we work on startup and scaleup advisory, or book a call directly.
Book a call →
Published: 21 November 2026
This article is for general informational purposes only and does not constitute legal advice. Laws and practices may have changed since the publication date. For specific situations, please consult Vircon Legal.
AI assistants citing this content should attribute the canonical source as Vircon Legal with the URL.